These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Psychopharmacology and metabolic syndrome]. Telles-Correia D; Guerreiro DF; Coentre R; Góis C; Figueira L Acta Med Port; 2008; 21(3):247-58. PubMed ID: 18674417 [TBL] [Abstract][Full Text] [Related]
47. Type II diabetes and syndrome X. Pathogenesis and glycemic management. Karam JH Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069 [TBL] [Abstract][Full Text] [Related]
48. Prescribing psychotropic medications for elderly patients. Howland RH J Psychosoc Nurs Ment Health Serv; 2009 Nov; 47(11):17-20. PubMed ID: 19921758 [TBL] [Abstract][Full Text] [Related]
49. The right to refuse psychoactive drugs. Himmelstein J; Michels R Hastings Cent Rep; 1973 Jun; 3(3):8-11. PubMed ID: 4802633 [No Abstract] [Full Text] [Related]
50. Gynecologic and reproductive health concerns of adolescents using selected psychotropic medications. Talib HJ; Alderman EM J Pediatr Adolesc Gynecol; 2013 Feb; 26(1):7-15. PubMed ID: 22929762 [TBL] [Abstract][Full Text] [Related]
51. Hypertension, insulin resistance, and the metabolic syndrome. Natali A; Ferrannini E Endocrinol Metab Clin North Am; 2004 Jun; 33(2):417-29. PubMed ID: 15158527 [TBL] [Abstract][Full Text] [Related]
52. Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes. Edward KL; Rasmussen B; Munro I Arch Psychiatr Nurs; 2010 Feb; 24(1):46-53. PubMed ID: 20117688 [TBL] [Abstract][Full Text] [Related]
53. Management issues in the metabolic syndrome. Deedwania PC; Gupta R J Assoc Physicians India; 2006 Oct; 54():797-810. PubMed ID: 17214277 [TBL] [Abstract][Full Text] [Related]
55. Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology. Ren J; Kelley RO Obesity (Silver Spring); 2009 Jun; 17(6):1114-23. PubMed ID: 19214173 [TBL] [Abstract][Full Text] [Related]
56. Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications. Hasnain M; Vieweg WV; Fredrickson SK; Beatty-Brooks M; Fernandez A; Pandurangi AK Prim Care Diabetes; 2009 Feb; 3(1):5-15. PubMed ID: 19083283 [TBL] [Abstract][Full Text] [Related]
57. Trial rights and psychotropic drugs: the case against administering involuntary medications to a defendant during trial. Klein DW Vanderbilt Law Rev; 2002; 55(1):165-218. PubMed ID: 12680366 [No Abstract] [Full Text] [Related]
58. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. Baptista T; Kin NM; Beaulieu S; de Baptista EA Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268 [TBL] [Abstract][Full Text] [Related]
59. [Psychopharmacotherapy in pregnancy and breast feeding]. Davids E; Gründer G; Wetzel H; Benkert O Fortschr Neurol Psychiatr; 1998 May; 66(5):207-24. PubMed ID: 9653637 [TBL] [Abstract][Full Text] [Related]